FYI. I wasn't aware of Graybug Vision/GRAY until recently, until seeing a Retina MD newsletter reporting the results of a ph2 study that they were involved in.
Apparently not good & the stock tanked about 50%. After a little digging & wondering if the dip was buyable, discovered that their microparticle depot formulation of sunitinib actually blocks all VEGF pathways (A-D) and PLGF......and they where looking to extend injections to 6 months vs SOC/Eylea.
This made me a little nervous about OPT. But....
The topline release reports BCVA was "lower" than Eylea. Poor wording for a news release IMO. After emailing IR at GRAY, they confirmed that vision (9 letters in 20 pts) was worse than the Eylea comparator arm. Whew....
No wonder GRAY hasn't significantly recovered. Patients & their doctors want to maintain vision vs extend injection timelines.
Thinking of OPT competitors
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
0.025(3.03%) |
Mkt cap ! $1.046B | |||
| Open | High | Low | Value | Volume |
| 82.0¢ | 87.0¢ | 81.0¢ | $2.966M | 3.483M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 84.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 980 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |